Mark P de Souza

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 7

Top Topics

Middle Cerebral Artery

Top Venues

Science advances

Science translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Kavita Y Sarin, Mark Bradshaw, Chris O'Mara, Jahanbanoo Shahryari, John Kincaid, Steven Kempers, John H Tu, Sunil Dhawan, Janet DuBois, David Wilson, Patrice Horwath, Mark P de Souza, Christopher Powala, Gerd G Kochendoerfer, Scott R Plotkin, Guy F Webster, Lu Q Le
Effect of NFX-179 MEK inhibitor on cutaneous neurofibromas in persons with neurofibromatosis type 1. Science advances 10 (18) (2024)
Stuart L Marcus, Mark P de Souza
Theranostic Uses of the Heme Pathway in Neuro-Oncology: Protoporphyrin IX (PpIX) and Its Journey from Photodynamic Therapy (PDT) through Photodynamic Diagnosis (PDD) to Sonodynamic Therapy (SDT). Cancers 16 (4) (2024)
Stuart L Marcus, Mark P de Souza
Theranostic Uses of the Heme Pathway in Neuro-Oncology: Protoporphyrin IX (PpIX) and Its Journey from Photodynamic Therapy (PDT) through Photodynamic Diagnosis (PDD) to Sonodynamic Therapy (SDT). Cancers 16 (4) (2024)
Kavita Y Sarin, Mark Bradshaw, Chris O'Mara, Jahanbanoo Shahryari, John Kincaid, Steven Kempers, John H Tu, Sunil Dhawan, Janet DuBois, David Wilson, Patrice Horwath, Mark P de Souza, Christopher Powala, Gerd G Kochendoerfer, Scott R Plotkin, Guy F Webster, Lu Q Le
Effect of NFX-179 MEK inhibitor on cutaneous neurofibromas in persons with neurofibromatosis type 1. Science advances 10 (18) (2024)
Stuart L Marcus, Mark P de Souza
Theranostic Uses of the Heme Pathway in Neuro-Oncology: Protoporphyrin IX (PpIX) and Its Journey from Photodynamic Therapy (PDT) through Photodynamic Diagnosis (PDD) to Sonodynamic Therapy (SDT). Cancers 16 (4) (2024)
Kavita Y Sarin, Mark Bradshaw, Chris O'Mara, Jahanbanoo Shahryari, John Kincaid, Steven Kempers, John H Tu, Sunil Dhawan, Janet DuBois, David Wilson, Patrice Horwath, Mark P de Souza, Christopher Powala, Gerd G Kochendoerfer, Scott R Plotkin, Guy F Webster, Lu Q Le
Effect of NFX-179 MEK inhibitor on cutaneous neurofibromas in persons with neurofibromatosis type 1. Science advances 10 (18) (2024)
Kavita Y Sarin, John Kincaid, Brittney R Sell, Jahanbanoo Shahryari, Matthew A J Duncton, Elaine Morefield, Wenchao Sun, Karol Prieto, Omar Chavez-Chiang, Carlos Moran Segura, Jonathan V Nguyen, Roderick T Bronson, Scott R Plotkin, Gerd G Kochendoerfer, Peter Fenn, Michael A Wootton, Christopher Powala, Mark P de Souza, Kenneth Y Tsai
Development of a MEK inhibitor, NFX-179, as a chemoprevention agent for squamous cell carcinoma. Science translational medicine 15 (717) (2023)